Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide
EP Europace · 2023
DOI: 10.1093/europace/euac218 ↗Kurz gefasst
Fachartikel in der Zeitschrift EP Europace, 2023. Verfasst von Molly O'Reilly und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Wolfson Drive, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, British Heart Foundation.
Abstract (Originalsprache)
Aims
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Pathogenic variants in genes encoding ion channels are associated with familial AF. The point mutation M1875T in the SCN5A gene, which encodes the α-subunit of the cardiac sodium channel Nav1.5, has been associated with increased atrial excitability and familial AF in patients. Methods and results We designed a new murine model carrying the Scn5a-M1875T mutation enabling us to study the effects of the Nav1.5 mutation in detail in vivo and in vitro using patch clamp and microelectrode recording of atrial cardiomyocytes, optical mapping, electrocardiogram, echocardiography, gravimetry, histology, and biochemistry. Atrial cardiomyocytes from newly generated adult Scn5a-M1875T+/− mice showed a selective increase in the early (peak) cardiac sodium current, larger action potential amplitude, and a faster peak upstroke velocity. Conduction slowing caused by the sodium channel blocker flecainide was less pronounced in Scn5a-M1875T+/− compared to wildtype atria. Overt hypertrophy or heart failure in Scn5a-M1875T+/− mice could be excluded.
Conclusion
The Scn5a-M1875T point mutation causes gain-of-function of the cardiac sodium channel. Our results suggest increased atrial peak sodium current as a potential trigger for increased atrial excitability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Wolfson Drive, Birmingham B15 2TT, UK.
- Department of Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands.
- University Center of Cardiovascular Science, University Heart and Vascular Center, UKE Hamburg, Martinistraße 52, Hamburg 20246, Germany.
- DZHK Standort Hamburg/Kiel/Luebeck, Martinistraße 52, Hamburg 20246, Germany.
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford, UK.
- Medical Faculty, Core Facility Transgenic animal and genetic engineering Models (TRAM), University of Muenster, Muenster, Germany.
ORCID-Profile: Molly O'Reilly, Laura C Sommerfeld, C O'Shea, S Broadway-Stringer, S Andaleeb, J S Reyat, S N Kabir, D Stastny, A Malinova, D Delbue, K Gehmlich, D Pavlovic, B V Skryabin, A P Holmes, P Kirchhof, L Fabritz
Förderung
- Wellcome Trust
- Medical Research Council
- British Heart Foundation
- Leducq Foundation
- Horizon
- MAESTRIA
- AFFECT EU
- European Union
Zitieren
APA
O'Reilly, M., Sommerfeld, L. C., O'Shea, C., Broadway-Stringer, S., Andaleeb, S., Reyat, J. S., Kabir, S. N., Stastny, D., Malinova, A., Delbue, D., Fortmueller, L., Gehmlich, K., Pavlovic, D., Skryabin, B. V., Holmes, A. P., Kirchhof, P., & Fabritz, L. (2023). Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide. EP Europace. https://doi.org/10.1093/europace/euac218
Vancouver
O'Reilly M, Sommerfeld LC, O'Shea C, Broadway-Stringer S, Andaleeb S, Reyat JS, et al. Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide. EP Europace. 2023. doi:10.1093/europace/euac218
BibTeX
@article{OReilly2023,
author = {O'Reilly, Molly and Sommerfeld, Laura C and O'Shea, C and Broadway-Stringer, S and Andaleeb, S and Reyat, J S and Kabir, S N and Stastny, D and Malinova, A and Delbue, D and Fortmueller, L and Gehmlich, K and Pavlovic, D and Skryabin, B V and Holmes, A P and Kirchhof, P and Fabritz, L},
title = {Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide},
journal = {EP Europace},
year = {2023},
doi = {10.1093/europace/euac218}
}
EUVIMED